BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37249550)

  • 21. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardio-oncology.
    Ghosh AK; Walker JM
    Br J Hosp Med (Lond); 2017 Jan; 78(1):C11-C13. PubMed ID: 28067553
    [No Abstract]   [Full Text] [Related]  

  • 24. Welcome to the Rising Stars in Cardio-Oncology Special Focus Issue.
    Cannon A; Neill J
    Future Cardiol; 2023 Sep; 19(11):515-517. PubMed ID: 37850469
    [No Abstract]   [Full Text] [Related]  

  • 25. Age-Related Considerations in Cardio-Oncology.
    Screever EM; Meijers WC; Moslehi JJ
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):103-113. PubMed ID: 33124480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy-naïve malignancy causes cardiovascular disease: a state-of-the-art cardio-oncology perspective.
    Ogilvie LM; Coyle-Asbil B; Brunt KR; Petrik J; Simpson JA
    Am J Physiol Heart Circ Physiol; 2024 Jun; 326(6):H1515-H1537. PubMed ID: 38639740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
    Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
    Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
    Tufano A; Coppola A; Galderisi M
    Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heart and cancer: cardio-oncology].
    Michel L; Rassaf T
    Herz; 2024 Mar; 49(2):111-117. PubMed ID: 38289420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Society of Cardiology Core Curriculum for cardio-oncology.
    López-Fernández T; Farmakis D; Ameri P; Asteggiano R; de Azambuja E; Aznar M; Barac A; Bayes-Genis A; Bax JJ; Bergler-Klein J; Boriani G; Celutkiene J; Coats A; Cohen-Solal A; Córdoba R; Cosyns B; Filippatos G; Fox K; Gulati G; Inciardi RM; Lee G; Mamas MA; Novo G; Plummer C; Psyrri A; Rakisheva A; Suter T; Tini G; Tocchetti CG; Toutouzas K; Wilhelm M; Metra M; Lyon AR; Rosano GMC
    Eur J Heart Fail; 2024 Apr; 26(4):754-771. PubMed ID: 38059343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
    Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
    Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.
    Attieh RM; Nunez B; Copeland-Halperin RS; Jhaveri KD
    Cardiorenal Med; 2024; 14(1):281-293. PubMed ID: 38684145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardio-oncology: an ongoing evolution.
    Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
    Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardio-Oncology-Beyond Anthracyclines and Ejection Fraction.
    Geenty PD; Gregory AT; Nolan M; Denniss AR; Pepe S; Sverdlov AL; Thomas L
    Heart Lung Circ; 2024 May; 33(5):547-552. PubMed ID: 38823894
    [No Abstract]   [Full Text] [Related]  

  • 37. Building bridges: the emerging field of cardio-oncology.
    Parashar S
    Future Cardiol; 2015 Jul; 11(4):377-82. PubMed ID: 26239677
    [No Abstract]   [Full Text] [Related]  

  • 38. Onco-cardiology: Present and future.
    Sueta D; Hokimoto S
    Int J Cardiol; 2016 Jul; 215():38-40. PubMed ID: 27107544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
    Sayed N; Ameen M; Wu JC
    Cardiovasc Res; 2019 Apr; 115(5):949-959. PubMed ID: 30768178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardio-Oncology - A new subspecialty with collaboration at its heart.
    Ghosh AK; Walker JM
    Indian Heart J; 2017; 69(4):556-562. PubMed ID: 28822531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.